Skip to content
Review Open access

WEARABLE-DETECTED ATRIAL FIBRILLATION ALERTS: CLINICAL YIELD, PSYCHOLOGICAL BURDEN, EQUITY, AND HEALTH-SYSTEM CONSEQUENCES - A STRUCTURED REVIEW

Aug 2026 · International Journal of Innovative Technologies in Social Science · 0 citations · 28 references

TL;DR

A photoplethysmographic alert should initiate risk assessment and electrocardiographic confirmation rather than be treated as a diagnosis or an indication for therapy, and clinical value is more likely when screening is targeted, follow-up responsibility is ex-plicit, communication reduces uncertainty, and programs evaluate patient-important outcomes, workload, and equity alongside detection yield.

Abstract

Background: Consumer smartwatches and wearable electrocardiographic monitors have moved part of atrial fibrillation (AF) screening into continuous, patient-initiated surveillance. Objective: To evaluate wearable-enabled AF detection in relation to diagnostic yield, clinical outcomes, overdiagnosis, psychological effects, health care utilization, equity, and governance. Materials and Methods: PubMed/MEDLINE was searched, with supplementary citation and guideline tracking. Twenty-nine publications were included in a structured narrative synthesis. Results: Large consumer-device studies found that irregular-rhythm notifications were un-common, and subsequent AF confirmation varied with device type, timing, and baseline risk. Randomized screening trials generally increased AF detection and anticoagulant initiation, but most did not demonstrate reductions in stroke, mortality, or hospitalization. Supported monitor-ing programs usually did not increase anxiety, whereas observational studies of routine weara-ble use identified greater symptom preoccupation, treatment concern, clinician contact, and di-agnostic activity. Consumer ownership and digital capability may also reproduce existing ine-qualities in access. Conclusions: A photoplethysmographic alert should initiate risk assessment and electrocardiographic confirmation rather than be treated as a diagnosis or an indication for therapy. Clinical value is more likely when screening is targeted, follow-up responsibility is ex-plicit, communication reduces uncertainty, and programs evaluate patient-important outcomes, workload, and equity alongside detection yield.

Read PDF

Similar papers

Review Open access Sep 2026

ATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS

Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of con...

R. Kołodziej, Kacper Szpanelewski, Jakub Klecha et al. · 0 citations
Review Open access Sep 2026

Wearable Devices in Cardiovascular Care: A Narrative Review of the Transition Toward Predictive, Preventive, Personalized, and Participatory Medicine

Cardiovascular diseases remain the leading cause of global mortality, yet conventional diagnostics are episodic and clinic-centered, missing the dynamic physiological events that unfold between encounters. Wearable devices offer continuous, real-world monitoring and, together with artificial intelligence, digital bioma...

Simona Steliana Tudor, Ancuța Elena Țupu, A. Munteanu et al. · 0 citations
Open access Sep 2026

Feasibility of Mobile Single-Lead Electrocardiogram Screening for Atrial Fibrillation: Multicenter Cross-Sectional Study

Mobile single-lead ECG screening is feasible in routine inpatient and outpatient settings and identified a substantial prevalence of AF, which increased with age, and underscores the potential of wearable ECG devices to facilitate early detection of AF.

Roberto Fenske, Denise Rossa, Christian Butter et al. · 0 citations
Review Open access Aug 2026

WEARABLE DEVICES IN HYPERTENSION SELF-MANAGEMENT: PATIENT ENGAGEMENT, CLINICAL OUTCOMES, AND BARRIERS TO LONG-TERM ADOPTION

Wearable and connected devices should be treated as components of an organized self-management system rather than stand-alone therapies, and future implementation should prioritize validated measurement, low-burden design, human support, interoperability, and equity-sensitive evaluation over device novelty.

Radosław Sciepuro, Marta Czarnowska, Nina Czarnowska · 0 citations
Review Open access Sep 2026

From wrist to heart: clinical validation and real-world translation of wearable and portable AI-enhanced electrocardiography

Abstract Wearable and portable electrocardiogram (ECG) devices are shifting cardiovascular monitoring beyond clinician-directed testing, driven by consumer-led self-monitoring, remote care, and preventive cardiology. Artificial intelligence (AI) may enhance the value of these devices by supporting automated interpretat...

A. El-Medany, A. Birdi, Aron Abraham et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.